跳至主要内容
临床试验/EUCTR2018-000910-39-IT
EUCTR2018-000910-39-IT进行中(未招募)1 期

Efficacy of tranexamic acid in reducing post-operative bleeding in oncologic-reconstructive breast surgery - Topical use of tranexamic acid in reconstructive breast surgery

AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE0 个研究点目标入组 84 人开始时间: 2021年9月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Adult women, capable of understanding and will, affected by breast cancer and candidate to mastectomy and immediate breast reconstruction with implants.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 55
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 29

排除标准

  • Anamnesis of thromboembolism, known pro-coagulative alterations, ASA (American Society of Anesthesiology) Score IV

研究者

发起方
AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE

相似试验